详情页 - 河北大学附属医院知识库

当前位置：首页 > 详情页

The Efficacy and Safety Profile of Ixazomib-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma in Routine Clinical Practice: Real World Data from a Multi-Center Study in China

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：

机构： [1]Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China [2]Department of Hematology, Beijing Jishuitan Hospital, Beijing, China [3]Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China [4]Anhui Provincial Cancer Hospital, Hefei, China [5]The Second Affiliated Hospital of Soochow University, Suzhou, China [6]Department of Hematology, Nanjing University Medical School,the Affiliated Nanjing Drum Tower Hospital, Nanjing, China [7]The First Affilliated Hospital of Soochow University, Suzhou, China [8]The First Affiliated Hospital of Xiamen University, Xiamen, China [9]Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China [10]Wuxi People Hospital, Wuxi, China [11]The Affiliated Hospital of Hebei University, Baoding, China [12]Shengjing Hospital of China Medical University, Shengjing, China [13]The First Affiliated Hospital of Guangxi Medical University, Guangxi, China [14]Zhujiang Hospital of Southern Medical University, Guangzhou, China

出处：

DOI：

ISSN：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 1 区

医学

小类 | 1 区血液学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区血液学

JCR分区：

出版当年[2019]版：

Q1 HEMATOLOGY

最新[2023]版：

Q1 HEMATOLOGY

影响因子： 21.1 最新[2023版] 19.2 最新五年平均 17.794 出版当年[2019版] 14.892 出版当年五年平均 16.601 出版前一年[2018版] 23.629 出版后一年[2020版]

第一作者：

第一作者机构： [1]Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China

共同第一作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：